A TNM-based clinical staging system of ocular adnexal lymphomas

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 8, 2009, Pages 1262-1267

  Coupland, Sarah E ^a   White, Valerie A ^b   Rootman, Jack ^b   Damato, Bertil ^c   Finger, Paul T ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^d NEW YORK EYE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; EYE TUMOR; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULAR ADNEXAL LYMPHOMA; ORBIT TUMOR; PRIMARY TUMOR; PROGNOSIS; MARGINAL ZONE LYMPHOMA; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE;

EYE NEOPLASMS; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 69149091774     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. White WL, Ferry JA, Harris NL, Grove AS Jr. Ocular adnexal lymphoma: a clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology. 1995;102(12):1994-2006.
2. Coupland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases. Ophthalmology. 1998;105(8):1430- 1441. (Pubitemid 28509761)
3. Jakobiec FA, Knowles DM. An overview of ocular adnexal lymphoid tumors. Trans Am Ophthalmol Soc. 1989;87:420-442 discussion 442-444.
4. Jenkins C, Rose GE, Bunce C, et al. Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol. 2000;84(8):907-913. (Pubitemid 30599102)
5. Coupland SE, Hellmich M, Auw-Haedrich C, Lee W, Stein H. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefes Arch Clin Exp Ophthalmol. 2004;242(2):130-145. (Pubitemid 38324966)
6. Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LL. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood. 2006;108(5):1451-1460. (Pubitemid 44316108)
7. Jakobiec FA. Ocular adnexal lymphoid tumors: progress in need of clarification. Am J Ophthalmol. 2008;145(6):941-950.
8. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008:214. World Health Organization Classification of Tumours; vol 2.
9. Coupland SE, Foss HD, Assaf C, et al. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology. 1999; 106(11):2109-2120. (Pubitemid 30194233)
10. Woog JJ, Kim YD, Yeatts RP, et al. Natural Killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology. 2006;113(1):140-147. (Pubitemid 43021740)
11. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31(11):1860-1861.
12. Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas [in German]. Strahlentherapie. 1977;153(4):218-221. (Pubitemid 8097721)
13. Ruskoné-Fourmestraux A, Dragosics B, Morgner A, Wotherspoon AC, de Jong D. Paris staging system for primary gastrointestinal lymphomas. Gut. 2003; 52(6):912-916. (Pubitemid 36613505)
14. Gardiner JA, White VA, Gascoyne RD, Rootman J. Histopathologic, immunophenotypic and genotypic analyses in ocular adnexal lymphoproliferative disorders. Aust N Z J Ophthalmol. 1992;20(3):247-251. (Pubitemid 23197654)
15. Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol. 2007;31(2):170-184. (Pubitemid 46175017)
16. Hatef E, Roberts D, McLaughlin P, Pro B, Esmaeli B. Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphoma. Arch Ophthalmol. 2007;125(12):1663-1667. (Pubitemid 350254881)
17. Plaisier MB, Sie-Go DM, Berendschot TT, Petersen EJ, Mourits MP. Ocular adnexal lymphoma classified using the WHO classification: not only histology and stage, but also gender is a predictor of outcome. Orbit. 2007;26(2):83-88.
18. Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol. 1990;21(9):959-973.
19. Johnson TE, Tse DT, Byrne GE Jr, et al. Ocular-adnexal lymphoid tumors: a clinicopathologic and molecular genetic study of 77 patients. Ophthal Plast Reconstr Surg. 1999;15(3):171-179. (Pubitemid 30438879)
20. Shields CL, Shields JA, Carvalho C, Rundle P, Smith AF. Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology. 2001;108(5):979-984. (Pubitemid 32374256)
21. Wanyura H, Uliasz M, Kaminski A, Samolczyk-Wanyura D, Smolarz-Wojnowska A. Diagnostic difficulties and treatment of non-Hodgkin lymphoma of the orbit. J Craniomaxillofac Surg. 2007;35(1):39-47. (Pubitemid 46291675)
22. Martinet S, Ozsahin M, Belkacémi Y, et al. Outcome and prognostic factors in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55(4):892-898. (Pubitemid 36292130)
23. Valenzuela AA, Allen C, Grimes D,Wong D, Sullivan TJ. Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology. 2006;113(12):2331-2337. (Pubitemid 44848369)
24. Roe RH, Finger PT, Kurli M, Tena LB, Iacob CE. Whole-body positron emission tomography/computed tomography imaging and staging of orbital lymphoma. Ophthalmology. 2006;113(10):1854-1858. (Pubitemid 44442432)
25. Meunier J, Rouic L, Dendale R, et al. Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors. Leuk Lymphoma. 2006;47(7):1295-1305. (Pubitemid 44269637)
26. Coupland SE, White V, Rootman J, et al. TNM Staging of Ocular Adnexal Lymphomas. In: Edge SE, Byrd DR, Carducci MA, Compton CA, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009.
27. Knowles DM, ed. Neoplastic Hematopathology. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001.
28. Sigelman J, Jakobiec FA. Lymphoid lesions of the conjunctiva: relation of histopathology to clinical outcome. Ophthalmology. 1978;85(8):818-843. (Pubitemid 9027610)
29. Looi A, Gascoyne RD, Chhanabhai M, Connors JM, Rootman J, WhiteVA. Mantle cell lymphoma in the ocular adnexal region. Ophthalmology. 2005; 112(1):114-119. (Pubitemid 40075329)
30. Coupland SE, Hummel M, Stein H. Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv Ophthalmol. 2002;47(5):470-490. (Pubitemid 35345161)
31. Medeiros LJ, Harris NL. Lymphoid infiltrates of the orbit and conjunctiva: a morphologic and immunophenotypic study of 99 cases. Am J Surg Pathol. 1989; 13(6):459-471.
32. Auw-Haedrich C, Coupland SE, Kapp A, Schmitt-Gräff A, Buchen R, Witschel H. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Br J Ophthalmol. 2001;85(1):63-69. (Pubitemid 32060197)
33. McKelvie PA, McNab A, Francis IC, Fox R, O'Day J. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Experiment Ophthalmol. 2001; 29(6):387-393. (Pubitemid 34036740)
34. Sharara N, Holden JT, Wojno TH, Feinberg AS, Grossniklaus HE. Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric, and molecular analysis of forty-three cases. Ophthalmology. 2003;110(6):1245-1254. (Pubitemid 36676662)
35. Charlotte F, Doghmi K, Cassoux N, et al. Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases. Virchows Arch. 2006;448(4):506-516.
36. Ness GO, Lybæk H, Arnes J, Rødahl E. Chromosomal imbalances in lymphoid tumors of the orbit. Invest Ophthalmol Vis Sci. 2002;43(1):9-14. (Pubitemid 34032433)
37. Matteucci C, Galieni P, Leoncini L, et al. Typical genomic imbalances in primary MALT lymphoma of the orbit. J Pathol. 2003;200(5):656-660. (Pubitemid 36987316)
38. Tanimoto K, Sekiguchi N, Yokota Y, et al. Fluorescence in situ hybridization (FISH) analysis of primary ocular adnexal MALT lymphoma. BMC Cancer. 2006; 6:249. (Pubitemid 44696824)
39. Ruiz A, Reischl U, Swerdlow SH, et al. Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci. Am J Surg Pathol. 2007;31(5):792-802. (Pubitemid 46684221)
40. Kim WS, Honma K, Karnan S, et al. Genome-wide array-based comparative genomic hybridization of ocular marginal zone b cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma. Genes Chromosomes Cancer. 2007;46(8):776-783. (Pubitemid 46912348)
41. Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3 is the target gene of chromosomal band 6q23.3-q.24.1 loss in ocular adnexal marginal zone B-cell lymphoma. Genes Chromosomes Cancer. 2008;47(1):1-7. (Pubitemid 350191458)